Arsen Osipov

This is an early safety study for people with advanced pancreatic cancer that has spread and stopped responding to standard chemotherapy. It will test a combination of two drugs, cosibelimab and balixafortide, to find the safest dose and see if the treatment is tolerable. The mai…